发明名称 Steatohepatitis-liver cancer model animal
摘要 Fatty liver was induced by administering agents for inducing organ inflammation to experimental animals to evoke insulin resistance and by rearing them with high-fat diets. As a result, steatohepatitis was successfully induced in the animals. The animals show pathological findings similar to those of humans. By using these model animals, substances for treating or preventing diseases can be efficiently screened and the efficacy of medicinal substances can be effectively evaluated.
申请公布号 US9596834(B2) 申请公布日期 2017.03.21
申请号 US201414191942 申请日期 2014.02.27
申请人 Stelic Institute of Regenerative Medicine, Stelic Institute & Co. 发明人 Yoneyama Hiroyuki;Fujii Masato
分类号 A01K67/00;A01K67/027 主分类号 A01K67/00
代理机构 Bozicevic, Field & Francis LLP 代理人 Bozicevic Karl;Bozicevic, Field & Francis LLP
主权项 1. A non-human animal model, which is produced by: (a) administering to a non-human mammal of one to five days old an N-acetyl-β-D-glucosaminidase inhibitor in an amount sufficient to induce organ inflammation wherein the inhibitor is selected from the group consisting of streptozotocin and Pugnac; (b) rearing the mammal with a high-fat diet over a period of time sufficient to induce liver cirrhosis; and (c) further rearing the mammal with a high-fat diet over a period of time sufficient to induce liver cancer caused by cirrhosis, developed such that it displaces normal liver cells of the mammal.
地址 Tokyo JP